Literature DB >> 23264550

Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature.

Madhura Castelino1, Janice Abbott, Kathleen McElhone, Lee-Suan Teh.   

Abstract

OBJECTIVE: A review of the literature was undertaken to evaluate the development and psychometric properties of health-related quality of life (HRQoL) measures used in adults with SLE. This information will help clinicians make an informed choice about the measures most appropriate for research and clinical practice.
METHODS: Using the key words lupus and quality of life, full original papers in English were identified from six databases: OVID MEDLINE, EMBASE, Allied and Complementary Medicine, Psychinfo, Web of Science and Health and Psychosocial Instruments. Only studies describing the validation of HRQoL measures in adult SLE patients were retrieved.
RESULTS: Thirteen papers were relevant; five evaluated generic instruments [QOLS-S (n = 1), EQ-5D/SF-6D (n = 1), SF-36 (n = 3)] and eight evaluated disease-specific measures [L-QOL (n = 1), LupusQoL (UK) (n = 1), LupusQoL (US) (n = 1), SSC (n = 2), SLEQOL (n = 3)]. For the generic measures, there is moderate evidence of good content validity and internal consistency, whereas there is strong evidence for both these psychometric properties in disease-specific measures. There is limited to moderate evidence to support the construct validity and test-retest reliability for the disease-specific measures. Responsiveness and floor/ceiling effects have not been adequately investigated in any of the measures.
CONCLUSIONS: Direct comparison of the psychometric properties was difficult because of the different methodologies employed in the development and evaluation of the different HRQoL measures. However, there is supportive evidence that multidimensional disease-specific measures are the most suitable in terms of content and internal reliability for use in studies of adult patients with SLE.

Entities:  

Mesh:

Year:  2012        PMID: 23264550     DOI: 10.1093/rheumatology/kes370

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

Review 1.  Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Authors:  Anisha B Dua; Zahi Touma; Sergio Toloza; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

2.  Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Naeimehossadat Hosseini; Zahra Sayed Bonakdar; Ali Gholamrezaei; Leila Mirbagher
Journal:  Int J Rheumatol       Date:  2014-09-09

Review 3.  Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations.

Authors:  Sean Gavan; Ian Bruce; Katherine Payne
Journal:  Lupus Sci Med       Date:  2020-07

4.  Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients.

Authors:  Bustanul Arifin; Fredrick Dermawan Purba; Hendra Herman; John M F Adam; Jarir Atthobari; Catharina C M Schuiling-Veninga; Paul F M Krabbe; Maarten J Postma
Journal:  Health Qual Life Outcomes       Date:  2020-02-07       Impact factor: 3.186

5.  Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous.

Authors:  Mitra Moazzami; Patricia Katz; Dennisse Bonilla; Lisa Engel; Jiandong Su; Pooneh Akhavan; Nicole Anderson; Oshrat E Tayer-Shifman; Dorcas Beaton; Zahi Touma
Journal:  Lupus       Date:  2021-11-19       Impact factor: 2.911

6.  Silent Burdens in Disease: Fatigue and Depression in SLE.

Authors:  R Fonseca; M Bernardes; G Terroso; M de Sousa; M Figueiredo-Braga
Journal:  Autoimmune Dis       Date:  2014-01-28

7.  Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.

Authors:  Kathleen McElhone; Janice Abbott; Chris Sutton; Montana Mullen; Peter Lanyon; Anisur Rahman; Chee-Seng Yee; Mohammed Akil; Ian N Bruce; Yasmeen Ahmad; Caroline Gordon; Lee-Suan Teh
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-09-02       Impact factor: 4.794

Review 8.  What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews.

Authors:  Aureliano Paolo Finch; John Edward Brazier; Clara Mukuria
Journal:  Eur J Health Econ       Date:  2017-05-30

9.  Patient-reported outcome measures for use in clinical trials of SLE: a review.

Authors:  Zara Izadi; Julie Gandrup; Patricia P Katz; Jinoos Yazdany
Journal:  Lupus Sci Med       Date:  2018-08-21

10.  Capturing the patient experience in systemic lupus erythematosus: Are widely used measures fit-for-purpose and adherent to FDA PRO guidance recommendations?

Authors:  Kayleigh R Majercak; Eleanor M Perfetto; Ester Villalonga-Olives
Journal:  J Patient Rep Outcomes       Date:  2022-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.